Lsv Asset Management Medpace Holdings, Inc. Transaction History

Lsv Asset Management

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$227.52 - $312.68 $10.4 Million - $14.3 Million	-45,879 Reduced 90.35%	4,900 $1.5 Million
Q3 2023 Nov 03, 2023	SELL	$233.98 - $281.67 $803,955 - $967,818	-3,436 Reduced 6.34%	50,779 $12.3 Million
Q2 2023 Aug 02, 2023	SELL	$187.26 - $240.17 $2,621 - $3,362	-14 Reduced 0.03%	54,215 $13 Million
Q1 2023 May 02, 2023	BUY	$174.31 - $239.52 $9.28 Million - $12.7 Million	53,222 Added 5285.2%	54,229 $10.2 Million
Q4 2022 Feb 08, 2023	BUY	$153.06 - $226.57 $154,131 - $228,155	1,007 New	1,007 $214,000
Q2 2020 Aug 05, 2020	SELL	$68.08 - $95.68 $129,352 - $181,792	-1,900 Closed	0 $0
Q1 2020 May 07, 2020	BUY	$61.71 - $101.95 $117,249 - $193,705	1,900 New	1,900 $139,000
Q1 2019 May 07, 2019	SELL	$49.38 - $70.58 $997,476 - $1.43 Million	-20,200 Closed	0 $0
Q4 2018 Feb 05, 2019	SELL	$46.97 - $63.98 $661,384 - $900,902	-14,081 Reduced 41.08%	20,200 $1.07 Million
Q3 2018 Nov 06, 2018	SELL	$43.25 - $63.74 $367,625 - $541,790	-8,500 Reduced 19.87%	34,281 $2.05 Million
Q1 2018 May 04, 2018	BUY	$32.03 - $39.05 $904,655 - $1.1 Million	28,244 Added 194.29%	42,781 $1.49 Million
Q4 2017 Feb 01, 2018	BUY	$32.46 - $38.31 $471,871 - $556,912	14,537	14,537 $0

617

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.8B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Lsv Asset Management, based on Form 13F filings with the SEC.

Stay updated on Lsv Asset Management with notifications on news.